Table 3.

Diagnostic performance of non-invasive stress tests to identify graft failure and native disease progression post coronary artery bypass graft surgery.

References	Modality	Type of stress	Time from CABG (years)	Number of patients	Study population symptom status	Sensitivity (%)	Specificity (%)
Pittella et al. (97)	Echocardiography	Dobutamine	0.32	25	Asymptomatic patients	83	69
Hoffman et al. (98)	Echocardiography	Dobutamine	6.4	60	Symptomatic [45] and asymptomatic [15] patients	78	86
Sawada et al. (99)	Echocardiography	Exercise	6.3	41	Symptomatic [23] and asymptomatic [18] patients	88	86
Chirillo et al. (100)	Echocardiography	Dipyridamole	2.2	106	Patients scheduled to undergo coronary angiography	67	91
Elhendy et al. (101)	Echocardiography	Dobutamine	5.1	60	Both symptomatic [38] and asymptomatic [12] patients	78	89
Kafka et al. (102)	Echocardiography	Exercise	3.6	182	Mostly asymptomatic patients [148]	77	96
Crouse et al. (116)	Echocardiography	Exercise	7	125	Mainly symptomatic patients [96]	98	92
Al Aloul et al. (88)	SPECT	Exercise	1	79	Unselected cohort prospectively assessed 1 year post CABG	77	69
Pfisterer et al. (107)	SPECT	Exercise	12	55	Symptomatic [26] and asymptomatic [29] patients	80	88
Khoury et al. (108)	SPECT	Adenosine	6.7	109	Wide range of indications for cohort selection, including “periodic check-up” in 31 patients	96	61
Lakkis et al. (109)	SPECT	Exercise	4.2	50	30 patients with typical and 20 patients with atypical chest pain	80	87
Klein et al. (96)	Perfusion CMR	Adenosine	8	78	Suspicion of progression of stable angina	77	90
Bernhardt et al. (57)	Perfusion CMR	Adenosine	1.2	110	Clinical indication for invasive angiography	73	77
Klein et al. (86)*	Perfusion CMR Dobutamine	Dobutamine (wall motion analysis)	9.5	109	Data not available	88	96

SPECT, Single-Photon Emission Computed Tomography; CMR, Cardiac Magnetic Resonance; PET, Positron Emission Tomography.

^*Abstract only.